Publications of the group
Here we list the publications that the group has written or contributed to.
Accepted or published
2026
Roberts, K., Palmer, J., Volpe, J., Zhong, W. and McIntosh, A., 2026. Quantitative Dose Optimization for Gene Therapy Trials: Implications for Project Optimus and Early-Phase Design. Pharmaceutical Statistics, 25(5). doi
Anderson, P., Ananthakrishnan, R., Xu, Z., Rantell, K.R., Bell, S., Li, D., Xue, A. and Chiang, A.Y., 2026. Statistical analysis plan considerations for autologous cell and cell-based gene therapy clinical trials. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Ananthakrishnan, R., Adiwijaya, B., Chiang, A.Y., Han, C., He, Q.A., Lewandowski, A., Liu, R., Shen, F., Sun, H. and Li, D., 2026. Overview of dose- finding designs and trials in cell and gene therapies. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Anderson, P., Xu, Z., Degtyarev, E., Ananthakrishnan, R., Ballarini, N., He, A., Zhang, W. and Li, D., 2026. Pivotal trial design considerations for new and next generation cell and gene therapies. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Choi, S. and Dave, K., 2026. A systematic analysis of the inherent dose uncertainty in autologous CAR T-cell products. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Kang, R., Yamaguchi, Y. and Han, C., 2026. Bayesian quantitative decision- making framework in cell and gene therapy development for rare diseases. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Kim, Y., Wen, S., Rantell, K.R., Xu, Z. and Anderson, P., 2026. Real-world data and evidence in the development of cell and gene therapies. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Speth, K., Sengupta, S., Shamsuzzaman, M., Whitmore, J., Li, D., Chiang, A.Y., Xu, Z. and Song, Q., 2026. Advancing cell and gene therapy: Application of AI/ML in clinical development and patient management. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Choi, S., Chiang, A.Y., Cheng, C., Dai, T., Yeh, T.M. and Pikounis, B., 2026. Applications of correlative analysis for chemistry, manufacturing and controls in cell and gene therapy. Journal of Biopharmaceutical Statistics. Advance online publication. doi
2025
Wen, S., Anderson, P., Duan, R., Sverdlov, O. and Chiang, A.Y., 2025. Estimands for long-term follow-up trials in gene therapy products. Journal of Biopharmaceutical Statistics. Advance online publication. doi
Yi, S., Wu, C., McIntosh, A., Santaella, M.E., Robinson, T.M. and Liao, M.Z., 2025. Cell and Gene Therapy: Transforming Treatment Paradigms for Patient- Centric Care. Clinical and Translational Science, 18(12). doi
2024
Li, D., Xu, Z., Wen, S., Ananthakrishnan, R., Kim, Y., Rantell, K.R., Anderson, P., Whitmore, J. and Chiang, A., 2024. Challenges and Lessons Learned in Autologous Chimeric Antigen Receptor T-Cell Therapy Development from a Statistical Perspective. Therapeutic Innovation & Regulatory Science, 58(5), pp.817–830. doi
McIntosh, A. and Sverdlov, O. eds., 2024. Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations. Chapman and Hall/CRC. doi
Submitted
Nothing under review at present.